Stay updated with breaking news from Michael Celano. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BALA CYNWYD, Pa., Feb. 16, 2024 -- Larimar Therapeutics, Inc. , a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the closing of...
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Rating) CFO Michael Celano purchased 5,000 shares of the stock in a transaction dated Wednesday, May 17th. The stock was bought at an average cost of $3.73 per share, with a total value of $18,650.00. Following the completion of the purchase, the chief financial officer now owns 112,746 shares […]
Larimar Therapeutics Reports Preliminary Top-line Data from Phase 2 Trial's 25 mg Cohort Showing Increases in Frataxin Levels in Patients with Friedreich's Ataxia and First Quarter 2023... | May 15, 2023
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Aug. 8, 2022.
BETHLEHEM, Pa., May 23, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, today announced that Carrie